TY - JOUR
T1 - The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
AU - Xie, Qing
AU - Bu, Weishu
AU - Bhatia, Smita
AU - Hare, Joan
AU - Somasundaram, Thayumanasamy
AU - Azzi, Arezki
AU - Chapman, Michael S.
PY - 2002/8
Y1 - 2002/8
N2 - The structure of the adeno-associated virus (AAV-2) has been determined to 3-Å resolution by x-ray crystallography. AAV is being developed as a vector for gene therapy to treat diseases including hemophilia, cancer, and cystic fibrosis. As in the distantly related autonomous parvoviruses, the capsid protein has a β-barrel fold, but long loops between the β-strands share little structural homology with other parvoviruses, leading to unique surface features. Most prominent are groups of threefold-related peaks, each an intimate association of loops from two neighboring subunits. Mutations affecting cell entry and receptor binding are clustered near the positively charged side of each peak, implicating the region in attachment to the cellular receptor, heparan sulfate proteoglycan. Amino acids involved in antibody binding are in the same general vicinity. The structure will guide rational engineering of vector capsids to tailor cellular targeting and to avoid immediate neutralization by an immune system sensitized by prior exposure to AAV.
AB - The structure of the adeno-associated virus (AAV-2) has been determined to 3-Å resolution by x-ray crystallography. AAV is being developed as a vector for gene therapy to treat diseases including hemophilia, cancer, and cystic fibrosis. As in the distantly related autonomous parvoviruses, the capsid protein has a β-barrel fold, but long loops between the β-strands share little structural homology with other parvoviruses, leading to unique surface features. Most prominent are groups of threefold-related peaks, each an intimate association of loops from two neighboring subunits. Mutations affecting cell entry and receptor binding are clustered near the positively charged side of each peak, implicating the region in attachment to the cellular receptor, heparan sulfate proteoglycan. Amino acids involved in antibody binding are in the same general vicinity. The structure will guide rational engineering of vector capsids to tailor cellular targeting and to avoid immediate neutralization by an immune system sensitized by prior exposure to AAV.
UR - http://www.scopus.com/inward/record.url?scp=0036678455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036678455&partnerID=8YFLogxK
U2 - 10.1073/pnas.162250899
DO - 10.1073/pnas.162250899
M3 - Article
C2 - 12136130
AN - SCOPUS:0036678455
VL - 99
SP - 10405
EP - 10410
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
SN - 0027-8424
IS - 16
ER -